Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wills

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitorsJ Hayler, P D Kane, D LeGrand, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 positionU Baettig, L Brown, D Brundish, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2011
Hypermorphic mutation of the voltage-gated sodium channel encoding gene Scn10a causes a dramatic stimulus-dependent neurobehavioral phenotypeAmanda L Blasius, Adrienne E Dubin, Matt J Petrus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirusS C Anderson, D E Johnson, M P Harris, et al.
Cancer Gene Therapy|November 1, 2001
Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancersC M Iqbal Ahmed, D E Johnson, G W Demers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2001
Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatmentI A Atencio, J B Avanzini, D Johnson, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitorsJ Hayler, P D Kane, D LeGrand, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 positionU Baettig, L Brown, D Brundish, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2011
Hypermorphic mutation of the voltage-gated sodium channel encoding gene Scn10a causes a dramatic stimulus-dependent neurobehavioral phenotypeAmanda L Blasius, Adrienne E Dubin, Matt J Petrus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirusS C Anderson, D E Johnson, M P Harris, et al.
Cancer Gene Therapy|November 1, 2001
Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancersC M Iqbal Ahmed, D E Johnson, G W Demers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2001
Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatmentI A Atencio, J B Avanzini, D Johnson, et al.
Pageof 7